| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 1.53e-14 | 46 | 37 | 8 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 1.63e-09 | 188 | 37 | 8 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | SHANK1 COL4A6 COL5A1 COL6A1 MYH8 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 EPB41 | 3.86e-07 | 891 | 37 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | C-rich single-stranded DNA binding | 1.00e-05 | 3 | 37 | 2 | GO:1990829 | |
| GeneOntologyMolecularFunction | chromatin loop anchoring activity | 9.29e-05 | 8 | 37 | 2 | GO:0140587 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.08e-04 | 134 | 37 | 4 | GO:0003697 | |
| GeneOntologyMolecularFunction | DNA-DNA tethering activity | 1.19e-04 | 9 | 37 | 2 | GO:0106260 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 2.18e-04 | 12 | 37 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | heparin binding | 4.27e-04 | 192 | 37 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | actin filament binding | 8.00e-04 | 227 | 37 | 4 | GO:0051015 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.48e-03 | 268 | 37 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.60e-03 | 694 | 37 | 6 | GO:0003729 | |
| GeneOntologyMolecularFunction | actin binding | 1.80e-03 | 479 | 37 | 5 | GO:0003779 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.91e-03 | 323 | 37 | 4 | GO:1901681 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 2.79e-06 | 377 | 35 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 2.84e-06 | 378 | 35 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 2.89e-06 | 379 | 35 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 8.17e-06 | 76 | 35 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 1.15e-04 | 912 | 35 | 8 | GO:0030029 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 1.60e-04 | 957 | 35 | 8 | GO:0097435 | |
| GeneOntologyBiologicalProcess | negative regulation of cGAS/STING signaling pathway | 1.83e-04 | 12 | 35 | 2 | GO:0160049 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 2.57e-04 | 73 | 35 | 3 | GO:0050879 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A6 COL5A1 COL6A1 COL11A2 C1QTNF7 COL16A1 COL25A1 COL19A1 MARCO COL28A1 | 5.93e-16 | 88 | 39 | 10 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 6.05e-08 | 21 | 39 | 4 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 1.49e-07 | 332 | 39 | 8 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 MARCO COL28A1 | 4.35e-07 | 530 | 39 | 9 | GO:0062023 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.31e-06 | 12 | 39 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.31e-06 | 12 | 39 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 MARCO COL28A1 | 2.55e-06 | 656 | 39 | 9 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 MARCO COL28A1 | 2.61e-06 | 658 | 39 | 9 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type V trimer | 2.03e-05 | 4 | 39 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 3.38e-05 | 5 | 39 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | basement membrane | 7.76e-05 | 122 | 39 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | myofibril | 1.47e-04 | 273 | 39 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.94e-04 | 290 | 39 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | supramolecular polymer | 2.68e-04 | 1187 | 39 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | myosin filament | 9.90e-04 | 25 | 39 | 2 | GO:0032982 | |
| GeneOntologyCellularComponent | sarcomere | 1.16e-03 | 249 | 39 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | focal adhesion | 1.18e-03 | 431 | 39 | 5 | GO:0005925 | |
| GeneOntologyCellularComponent | myosin II complex | 1.24e-03 | 28 | 39 | 2 | GO:0016460 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.28e-03 | 1179 | 39 | 8 | GO:0099512 | |
| GeneOntologyCellularComponent | cell-substrate junction | 1.33e-03 | 443 | 39 | 5 | GO:0030055 | |
| GeneOntologyCellularComponent | Z disc | 2.79e-03 | 151 | 39 | 3 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 3.64e-03 | 166 | 39 | 3 | GO:0031674 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 4.14e-03 | 576 | 39 | 5 | GO:0015629 | |
| GeneOntologyCellularComponent | myosin complex | 5.43e-03 | 59 | 39 | 2 | GO:0016459 | |
| GeneOntologyCellularComponent | anchoring junction | 8.90e-03 | 976 | 39 | 6 | GO:0070161 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL5A1 COL6A1 FLNA FLNC MYH8 COL11A2 RET COL25A1 MYO18B CTCF | 5.06e-05 | 730 | 18 | 10 | HP:0002644 |
| HumanPheno | Acetabular dysplasia | 7.16e-05 | 24 | 18 | 3 | HP:0008807 | |
| HumanPheno | Abnormal hip bone morphology | 1.47e-04 | 653 | 18 | 9 | HP:0003272 | |
| HumanPheno | Recurrent respiratory infections | 1.59e-04 | 660 | 18 | 9 | HP:0002205 | |
| HumanPheno | Abnormality of lower limb joint | COL5A1 BPTF COL6A1 FLNA FLNC MYH8 COL11A2 RET COL25A1 MYO18B CTCF | 1.67e-04 | 1027 | 18 | 11 | HP:0100491 |
| HumanPheno | Glossoptosis | 1.72e-04 | 32 | 18 | 3 | HP:0000162 | |
| HumanPheno | Micrognathia | COL5A1 BPTF COL6A1 FLNA MYH8 COL11A2 COL25A1 MYO18B TCOF1 CTCF | 1.79e-04 | 843 | 18 | 10 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | COL5A1 BPTF COL6A1 FLNA MYH8 COL11A2 COL25A1 MYO18B TCOF1 CTCF | 1.82e-04 | 845 | 18 | 10 | HP:0009118 |
| HumanPheno | Abnormality of the neck | 2.08e-04 | 858 | 18 | 10 | HP:0000464 | |
| HumanPheno | Limited knee flexion/extension | 2.45e-04 | 7 | 18 | 2 | HP:0005085 | |
| HumanPheno | Limited knee flexion | 2.45e-04 | 7 | 18 | 2 | HP:0006389 | |
| HumanPheno | Wrist flexion contracture | 2.89e-04 | 38 | 18 | 3 | HP:0001239 | |
| HumanPheno | Sandal gap | 2.96e-04 | 96 | 18 | 4 | HP:0001852 | |
| Domain | Collagen | COL4A6 COL5A1 COL6A1 COL11A2 C1QTNF7 COL16A1 COL25A1 COL19A1 MARCO COL28A1 | 5.09e-16 | 85 | 36 | 10 | PF01391 |
| Domain | Collagen | COL4A6 COL5A1 COL6A1 COL11A2 C1QTNF7 COL16A1 COL25A1 COL19A1 MARCO COL28A1 | 5.09e-16 | 85 | 36 | 10 | IPR008160 |
| Domain | KH_1 | 9.55e-09 | 38 | 36 | 5 | PF00013 | |
| Domain | - | 1.09e-08 | 39 | 36 | 5 | 3.30.1370.10 | |
| Domain | KH | 1.25e-08 | 40 | 36 | 5 | SM00322 | |
| Domain | KH_dom | 1.25e-08 | 40 | 36 | 5 | IPR004087 | |
| Domain | KH_TYPE_1 | 1.61e-08 | 42 | 36 | 5 | PS50084 | |
| Domain | KH_dom_type_1 | 2.05e-08 | 44 | 36 | 5 | IPR004088 | |
| Domain | TSPN | 1.00e-07 | 23 | 36 | 4 | SM00210 | |
| Domain | Laminin_G | 4.58e-06 | 58 | 36 | 4 | IPR001791 | |
| Domain | - | 3.27e-05 | 95 | 36 | 4 | 2.60.120.200 | |
| Domain | IG_FLMN | 1.61e-04 | 10 | 36 | 2 | SM00557 | |
| Domain | Filamin | 1.97e-04 | 11 | 36 | 2 | PF00630 | |
| Domain | NC1_FIB | 1.97e-04 | 11 | 36 | 2 | PS51461 | |
| Domain | Filamin/ABP280_rpt | 1.97e-04 | 11 | 36 | 2 | IPR001298 | |
| Domain | Fib_collagen_C | 1.97e-04 | 11 | 36 | 2 | IPR000885 | |
| Domain | Fib_collagen_C | 1.97e-04 | 11 | 36 | 2 | PD002078 | |
| Domain | Filamin/ABP280_repeat-like | 1.97e-04 | 11 | 36 | 2 | IPR017868 | |
| Domain | COLFI | 1.97e-04 | 11 | 36 | 2 | SM00038 | |
| Domain | COLFI | 1.97e-04 | 11 | 36 | 2 | PF01410 | |
| Domain | FILAMIN_REPEAT | 1.97e-04 | 11 | 36 | 2 | PS50194 | |
| Domain | Myosin-like_IQ_dom | 6.05e-04 | 19 | 36 | 2 | IPR027401 | |
| Domain | - | 6.05e-04 | 19 | 36 | 2 | 4.10.270.10 | |
| Domain | ConA-like_dom | 8.07e-04 | 219 | 36 | 4 | IPR013320 | |
| Domain | Actinin_actin-bd_CS | 8.91e-04 | 23 | 36 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 8.91e-04 | 23 | 36 | 2 | PS00020 | |
| Domain | ACTININ_1 | 8.91e-04 | 23 | 36 | 2 | PS00019 | |
| Domain | MYOSIN_MOTOR | 2.43e-03 | 38 | 36 | 2 | PS51456 | |
| Domain | Myosin_head | 2.43e-03 | 38 | 36 | 2 | PF00063 | |
| Domain | Myosin_head_motor_dom | 2.43e-03 | 38 | 36 | 2 | IPR001609 | |
| Domain | MYSc | 2.43e-03 | 38 | 36 | 2 | SM00242 | |
| Domain | Laminin_G_2 | 2.69e-03 | 40 | 36 | 2 | PF02210 | |
| Domain | LamG | 3.25e-03 | 44 | 36 | 2 | SM00282 | |
| Domain | VWA | 5.21e-03 | 56 | 36 | 2 | PF00092 | |
| Domain | CH | 6.96e-03 | 65 | 36 | 2 | SM00033 | |
| Domain | CH | 8.03e-03 | 70 | 36 | 2 | PF00307 | |
| Domain | IQ | 8.26e-03 | 71 | 36 | 2 | PF00612 | |
| Domain | - | 8.26e-03 | 71 | 36 | 2 | 1.10.418.10 | |
| Domain | CH | 8.71e-03 | 73 | 36 | 2 | PS50021 | |
| Domain | - | 8.94e-03 | 74 | 36 | 2 | 3.40.50.410 | |
| Domain | CH-domain | 9.18e-03 | 75 | 36 | 2 | IPR001715 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 5.28e-15 | 41 | 27 | 8 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 9.76e-15 | 44 | 27 | 8 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 1.59e-13 | 61 | 27 | 8 | MM14637 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 3.49e-13 | 67 | 27 | 8 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 9.99e-13 | 76 | 27 | 8 | MM14573 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 4.04e-12 | 90 | 27 | 8 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.34e-11 | 64 | 27 | 7 | M26953 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.88e-10 | 53 | 27 | 6 | MM14566 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.16e-09 | 140 | 27 | 7 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 1.86e-08 | 258 | 27 | 8 | MM14572 |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.26e-08 | 46 | 27 | 5 | M198 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 5.99e-08 | 300 | 27 | 8 | M610 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.31e-08 | 114 | 27 | 6 | MM14571 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.56e-07 | 74 | 27 | 5 | M160 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.70e-06 | 199 | 27 | 6 | M7253 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.31e-06 | 50 | 27 | 4 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.17e-06 | 61 | 27 | 4 | M27103 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.09e-06 | 66 | 27 | 4 | M18 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.25e-05 | 76 | 27 | 4 | MM14867 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.85e-05 | 84 | 27 | 4 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.94e-05 | 85 | 27 | 4 | M16441 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.99e-05 | 32 | 27 | 3 | MM14924 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.90e-04 | 59 | 27 | 3 | M27218 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.92e-04 | 11 | 27 | 2 | M48099 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.01e-04 | 76 | 27 | 3 | M27219 | |
| Pathway | WP_FOCAL_ADHESION | 4.14e-04 | 187 | 27 | 4 | MM15913 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 5.30e-04 | 18 | 27 | 2 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 5.30e-04 | 18 | 27 | 2 | M840 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.92e-04 | 19 | 27 | 2 | MM15512 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 6.57e-04 | 20 | 27 | 2 | MM15061 | |
| Pathway | WP_MRNA_PROCESSING | 1.48e-03 | 451 | 27 | 5 | MM15946 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.49e-03 | 30 | 27 | 2 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.49e-03 | 30 | 27 | 2 | MM15517 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.69e-03 | 32 | 27 | 2 | MM15326 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 1.80e-03 | 33 | 27 | 2 | M240 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.99e-03 | 132 | 27 | 3 | M11355 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 2.02e-03 | 35 | 27 | 2 | M16801 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.38e-03 | 38 | 27 | 2 | MM14969 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.77e-03 | 41 | 27 | 2 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.90e-03 | 42 | 27 | 2 | M7169 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.04e-03 | 43 | 27 | 2 | M39565 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.62e-03 | 47 | 27 | 2 | MM14925 | |
| Pubmed | 1.35e-12 | 4 | 39 | 4 | 14612387 | ||
| Pubmed | 6.74e-12 | 5 | 39 | 4 | 23640898 | ||
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 10936052 | ||
| Pubmed | 3.80e-10 | 153 | 39 | 7 | 25037231 | ||
| Pubmed | 3.46e-09 | 210 | 39 | 7 | 16537572 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BPTF ZNF384 FLNA PARP1 PCBP3 PCBP1 PCBP2 CTCF FUBP1 EPB41 STAU1 | 5.19e-09 | 954 | 39 | 11 | 36373674 |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 8.98e-09 | 135 | 39 | 6 | 28675934 | |
| Pubmed | 3.20e-08 | 167 | 39 | 6 | 22159717 | ||
| Pubmed | 4.23e-08 | 175 | 39 | 6 | 28071719 | ||
| Pubmed | 6.55e-08 | 494 | 39 | 8 | 26831064 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 9.93e-08 | 989 | 39 | 10 | 36424410 | |
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 8871564 | ||
| Pubmed | 1.32e-07 | 212 | 39 | 6 | 23463506 | ||
| Pubmed | 2.14e-07 | 11 | 39 | 3 | 36579465 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 7.18e-07 | 62 | 39 | 4 | 28344315 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 7.18e-07 | 934 | 39 | 9 | 33916271 | |
| Pubmed | 9.13e-07 | 295 | 39 | 6 | 26209609 | ||
| Pubmed | 1.07e-06 | 488 | 39 | 7 | 31324722 | ||
| Pubmed | PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type. | 1.23e-06 | 2 | 39 | 2 | 29976663 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7607214 | ||
| Pubmed | αCP Poly(C) binding proteins act as global regulators of alternative polyadenylation. | 1.23e-06 | 2 | 39 | 2 | 23629627 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20038529 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 8855318 | ||
| Pubmed | The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. | 1.23e-06 | 2 | 39 | 2 | 12003487 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12414943 | ||
| Pubmed | Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor. | 1.23e-06 | 2 | 39 | 2 | 30132844 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 10455157 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7689010 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26321255 | ||
| Pubmed | Identification of two KH domain proteins in the alpha-globin mRNP stability complex. | 1.23e-06 | 2 | 39 | 2 | 7556077 | |
| Pubmed | CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery. | 1.23e-06 | 2 | 39 | 2 | 18539602 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 10679933 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 26896798 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21752917 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 32647012 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 1.23e-06 | 2 | 39 | 2 | 24469451 | |
| Pubmed | 1.31e-06 | 72 | 39 | 4 | 31248990 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.54e-06 | 1024 | 39 | 9 | 24711643 | |
| Pubmed | 1.71e-06 | 21 | 39 | 3 | 16079250 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 1.91e-06 | 1367 | 39 | 10 | 32687490 | |
| Pubmed | 1.98e-06 | 22 | 39 | 3 | 18487259 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 2.22e-06 | 344 | 39 | 6 | 30333137 | |
| Pubmed | 2.39e-06 | 551 | 39 | 7 | 34728620 | ||
| Pubmed | β-Actin mRNA interactome mapping by proximity biotinylation. | 2.60e-06 | 24 | 39 | 3 | 31189591 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.64e-06 | 807 | 39 | 8 | 22681889 | |
| Pubmed | 2.69e-06 | 809 | 39 | 8 | 32129710 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.75e-06 | 357 | 39 | 6 | 37059091 | |
| Pubmed | 2.89e-06 | 360 | 39 | 6 | 33111431 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.16e-06 | 203 | 39 | 5 | 22083510 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 3.47e-06 | 583 | 39 | 7 | 29844126 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 19211566 | ||
| Pubmed | Functional interactions between NURF and Ctcf regulate gene expression. | 3.67e-06 | 3 | 39 | 2 | 25348714 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11252955 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12704190 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24480778 | ||
| Pubmed | RNA-Binding Proteins PCBP1 and PCBP2 Are Critical Determinants of Murine Erythropoiesis. | 3.67e-06 | 3 | 39 | 2 | 34180713 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12527772 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 34009784 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11038172 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 9234743 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 27628582 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11102480 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 24843120 | ||
| Pubmed | Regulation of BC200 RNA-mediated translation inhibition by hnRNP E1 and E2. | 3.67e-06 | 3 | 39 | 2 | 28027391 | |
| Pubmed | Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm. | 3.67e-06 | 3 | 39 | 2 | 17825253 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12970749 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12393796 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 8833161 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 32480040 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 9412467 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 11153914 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 36553626 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 3.94e-06 | 1149 | 39 | 9 | 35446349 | |
| Pubmed | 4.05e-06 | 1153 | 39 | 9 | 29845934 | ||
| Pubmed | 5.05e-06 | 397 | 39 | 6 | 21319273 | ||
| Pubmed | 5.20e-06 | 399 | 39 | 6 | 35987950 | ||
| Pubmed | 5.33e-06 | 226 | 39 | 5 | 31452512 | ||
| Pubmed | 6.16e-06 | 411 | 39 | 6 | 36652389 | ||
| Pubmed | 7.27e-06 | 653 | 39 | 7 | 22586326 | ||
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 7.34e-06 | 4 | 39 | 2 | 17683922 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 21730054 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 20554076 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 7.34e-06 | 4 | 39 | 2 | 22802962 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 23624467 | ||
| Pubmed | Interactions between collagen gene variants and risk of anterior cruciate ligament rupture. | 7.34e-06 | 4 | 39 | 2 | 25073002 | |
| Pubmed | An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. | 7.34e-06 | 4 | 39 | 2 | 10373504 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 12011088 | ||
| Pubmed | Targeted next-generation sequencing reveals multiple deleterious variants in OPLL-associated genes. | 7.34e-06 | 4 | 39 | 2 | 27246988 | |
| Pubmed | Interaction partners for human ZNF384/CIZ/NMP4--zyxin as a mediator for p130CAS signaling? | 7.34e-06 | 4 | 39 | 2 | 16510139 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 8.20e-06 | 247 | 39 | 5 | 39238192 | |
| Pubmed | 9.20e-06 | 441 | 39 | 6 | 31239290 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 9.56e-06 | 444 | 39 | 6 | 34795231 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.01e-05 | 258 | 39 | 5 | 37794589 | |
| Pubmed | 1.05e-05 | 1297 | 39 | 9 | 33545068 | ||
| Pubmed | 1.22e-05 | 707 | 39 | 7 | 19738201 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 33414446 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 19366992 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12006559 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 17360453 | ||
| Interaction | CHMP4B interactions | COL5A1 FLNA FLNC PCBP3 RET SUCLG1 TCOF1 PCBP1 PCBP2 CTCF STAU1 | 8.31e-08 | 727 | 39 | 11 | int:CHMP4B |
| Interaction | PCBP1 interactions | 4.16e-07 | 671 | 39 | 10 | int:PCBP1 | |
| Interaction | DCN interactions | 1.40e-06 | 43 | 39 | 4 | int:DCN | |
| Interaction | SMC5 interactions | BPTF ZNF384 FLNA PARP1 PCBP3 PCBP1 PCBP2 CTCF FUBP1 EPB41 STAU1 | 1.98e-06 | 1000 | 39 | 11 | int:SMC5 |
| Interaction | COLGALT2 interactions | 8.41e-06 | 67 | 39 | 4 | int:COLGALT2 | |
| Interaction | PAICS interactions | 1.06e-05 | 263 | 39 | 6 | int:PAICS | |
| Interaction | HSPB7 interactions | 1.32e-05 | 24 | 39 | 3 | int:HSPB7 | |
| Interaction | PCBP2 interactions | 1.77e-05 | 288 | 39 | 6 | int:PCBP2 | |
| Interaction | PLOD1 interactions | 1.92e-05 | 292 | 39 | 6 | int:PLOD1 | |
| Interaction | THOC6 interactions | 2.37e-05 | 87 | 39 | 4 | int:THOC6 | |
| Interaction | CUL7 interactions | 2.62e-05 | 845 | 39 | 9 | int:CUL7 | |
| Interaction | PLOD3 interactions | 2.62e-05 | 183 | 39 | 5 | int:PLOD3 | |
| Interaction | HDLBP interactions | 2.87e-05 | 855 | 39 | 9 | int:HDLBP | |
| Interaction | H1-2 interactions | 3.39e-05 | 666 | 39 | 8 | int:H1-2 | |
| Interaction | ECT2 interactions | 3.83e-05 | 887 | 39 | 9 | int:ECT2 | |
| Interaction | MAPT interactions | 3.88e-05 | 1119 | 39 | 10 | int:MAPT | |
| Interaction | SERBP1 interactions | PRKCD FLNA PCBP3 SUCLG1 TCOF1 PCBP1 PCBP2 CTCF FUBP1 EPB41 STAU1 | 5.87e-05 | 1432 | 39 | 11 | int:SERBP1 |
| Interaction | CEBPB interactions | BPTF ZNF384 FLNA PARP1 SUCLG1 TCOF1 PCBP1 CTCF DNAJA4 FUBP1 STAU1 | 6.30e-05 | 1443 | 39 | 11 | int:CEBPB |
| Interaction | FIP1L1 interactions | 7.01e-05 | 225 | 39 | 5 | int:FIP1L1 | |
| Interaction | AXL interactions | 7.08e-05 | 369 | 39 | 6 | int:AXL | |
| Interaction | COL8A2 interactions | 7.30e-05 | 42 | 39 | 3 | int:COL8A2 | |
| Interaction | NAA40 interactions | 8.17e-05 | 978 | 39 | 9 | int:NAA40 | |
| Interaction | IGSF8 interactions | 9.32e-05 | 239 | 39 | 5 | int:IGSF8 | |
| Interaction | BRCA1 interactions | 9.80e-05 | 1249 | 39 | 10 | int:BRCA1 | |
| Interaction | C1QTNF1 interactions | 1.02e-04 | 47 | 39 | 3 | int:C1QTNF1 | |
| Interaction | CDK2 interactions | 1.06e-04 | 783 | 39 | 8 | int:CDK2 | |
| Interaction | PCBP3 interactions | 1.14e-04 | 130 | 39 | 4 | int:PCBP3 | |
| Interaction | LAIR2 interactions | 1.16e-04 | 49 | 39 | 3 | int:LAIR2 | |
| Interaction | FSCN1 interactions | 1.17e-04 | 251 | 39 | 5 | int:FSCN1 | |
| Interaction | ITGB2 interactions | 1.21e-04 | 132 | 39 | 4 | int:ITGB2 | |
| Interaction | DCAF15 interactions | 1.26e-04 | 255 | 39 | 5 | int:DCAF15 | |
| Interaction | SMC1A interactions | 1.40e-04 | 418 | 39 | 6 | int:SMC1A | |
| Interaction | KIF20A interactions | 1.43e-04 | 1052 | 39 | 9 | int:KIF20A | |
| Interaction | EIF3E interactions | 1.46e-04 | 263 | 39 | 5 | int:EIF3E | |
| Interaction | PDLIM7 interactions | 1.49e-04 | 264 | 39 | 5 | int:PDLIM7 | |
| Interaction | C16orf96 interactions | 1.63e-04 | 10 | 39 | 2 | int:C16orf96 | |
| Interaction | ACTB interactions | 1.77e-04 | 1083 | 39 | 9 | int:ACTB | |
| Interaction | FN1 interactions | 1.83e-04 | 848 | 39 | 8 | int:FN1 | |
| Interaction | TIMP2 interactions | 1.86e-04 | 277 | 39 | 5 | int:TIMP2 | |
| Interaction | NSD2 interactions | 1.89e-04 | 278 | 39 | 5 | int:NSD2 | |
| Interaction | HNRNPD interactions | 1.96e-04 | 638 | 39 | 7 | int:HNRNPD | |
| Interaction | ARF4 interactions | 1.99e-04 | 281 | 39 | 5 | int:ARF4 | |
| Interaction | AIMP2 interactions | 2.00e-04 | 446 | 39 | 6 | int:AIMP2 | |
| Interaction | SMAD3 interactions | 2.02e-04 | 447 | 39 | 6 | int:SMAD3 | |
| Interaction | MYCN interactions | 2.14e-04 | 1373 | 39 | 10 | int:MYCN | |
| Interaction | MKI67 interactions | 2.16e-04 | 648 | 39 | 7 | int:MKI67 | |
| Interaction | U2AF2 interactions | 2.22e-04 | 651 | 39 | 7 | int:U2AF2 | |
| Interaction | H1-3 interactions | 2.34e-04 | 291 | 39 | 5 | int:H1-3 | |
| Interaction | USP48 interactions | 2.60e-04 | 668 | 39 | 7 | int:USP48 | |
| Interaction | POLR1B interactions | 2.66e-04 | 162 | 39 | 4 | int:POLR1B | |
| Interaction | AGO2 interactions | 2.71e-04 | 472 | 39 | 6 | int:AGO2 | |
| Interaction | CIC interactions | 2.72e-04 | 673 | 39 | 7 | int:CIC | |
| Interaction | VCAM1 interactions | 2.80e-04 | 475 | 39 | 6 | int:VCAM1 | |
| Interaction | SOX2 interactions | BPTF ZNF384 COL6A1 PRKCD FLNA PARP1 CTCF FUBP1 ARHGAP26 STAU1 | 2.84e-04 | 1422 | 39 | 10 | int:SOX2 |
| Interaction | FXR1 interactions | 2.87e-04 | 679 | 39 | 7 | int:FXR1 | |
| Interaction | SERPINH1 interactions | 2.95e-04 | 306 | 39 | 5 | int:SERPINH1 | |
| Interaction | MMP9 interactions | 2.95e-04 | 67 | 39 | 3 | int:MMP9 | |
| Interaction | HEXIM1 interactions | 3.03e-04 | 913 | 39 | 8 | int:HEXIM1 | |
| Interaction | CDK9 interactions | 3.03e-04 | 685 | 39 | 7 | int:CDK9 | |
| Interaction | FUBP1 interactions | 3.08e-04 | 309 | 39 | 5 | int:FUBP1 | |
| Interaction | ITGB3 interactions | 3.19e-04 | 170 | 39 | 4 | int:ITGB3 | |
| Interaction | CAMKK2 interactions | 3.21e-04 | 69 | 39 | 3 | int:CAMKK2 | |
| Interaction | ADARB1 interactions | 3.27e-04 | 489 | 39 | 6 | int:ADARB1 | |
| Interaction | RINL interactions | 3.27e-04 | 14 | 39 | 2 | int:RINL | |
| Interaction | RPL17-C18orf32 interactions | 3.27e-04 | 14 | 39 | 2 | int:RPL17-C18orf32 | |
| Interaction | PTK2 interactions | 3.36e-04 | 315 | 39 | 5 | int:PTK2 | |
| Interaction | HYOU1 interactions | 3.46e-04 | 317 | 39 | 5 | int:HYOU1 | |
| Interaction | MYO18B interactions | 3.77e-04 | 15 | 39 | 2 | int:MYO18B | |
| Interaction | ZNF384 interactions | 3.79e-04 | 73 | 39 | 3 | int:ZNF384 | |
| Interaction | MTDH interactions | 3.88e-04 | 505 | 39 | 6 | int:MTDH | |
| Interaction | NUDT5 interactions | 4.11e-04 | 75 | 39 | 3 | int:NUDT5 | |
| Interaction | SYNCRIP interactions | 4.13e-04 | 721 | 39 | 7 | int:SYNCRIP | |
| Interaction | KPNA2 interactions | 4.49e-04 | 519 | 39 | 6 | int:KPNA2 | |
| Interaction | APOBEC3C interactions | 4.58e-04 | 187 | 39 | 4 | int:APOBEC3C | |
| Interaction | CCAR2 interactions | 4.58e-04 | 337 | 39 | 5 | int:CCAR2 | |
| Interaction | NECAP1 interactions | 4.61e-04 | 78 | 39 | 3 | int:NECAP1 | |
| Interaction | SRSF3 interactions | 4.63e-04 | 522 | 39 | 6 | int:SRSF3 | |
| Interaction | HNF1B interactions | 4.86e-04 | 190 | 39 | 4 | int:HNF1B | |
| Interaction | QKI interactions | 4.86e-04 | 190 | 39 | 4 | int:QKI | |
| Interaction | STAT1 interactions | 4.90e-04 | 342 | 39 | 5 | int:STAT1 | |
| Interaction | SMCHD1 interactions | 4.96e-04 | 191 | 39 | 4 | int:SMCHD1 | |
| Interaction | SIRT7 interactions | 4.98e-04 | 744 | 39 | 7 | int:SIRT7 | |
| Interaction | TFE3 interactions | 5.03e-04 | 344 | 39 | 5 | int:TFE3 | |
| Interaction | AQR interactions | 5.06e-04 | 192 | 39 | 4 | int:AQR | |
| Interaction | COL16A1 interactions | 5.47e-04 | 18 | 39 | 2 | int:COL16A1 | |
| Interaction | CHD3 interactions | 5.52e-04 | 757 | 39 | 7 | int:CHD3 | |
| Interaction | WARS1 interactions | 5.57e-04 | 197 | 39 | 4 | int:WARS1 | |
| Interaction | NIPBL interactions | 5.79e-04 | 199 | 39 | 4 | int:NIPBL | |
| Interaction | RALY interactions | 5.88e-04 | 356 | 39 | 5 | int:RALY | |
| Interaction | TRIP6 interactions | 6.03e-04 | 358 | 39 | 5 | int:TRIP6 | |
| Interaction | CCT8 interactions | 6.10e-04 | 550 | 39 | 6 | int:CCT8 | |
| Interaction | CKMT2 interactions | 6.14e-04 | 86 | 39 | 3 | int:CKMT2 | |
| Interaction | MMP2 interactions | 6.35e-04 | 87 | 39 | 3 | int:MMP2 | |
| Interaction | VHL interactions | 6.76e-04 | 561 | 39 | 6 | int:VHL | |
| Interaction | TAGLN interactions | 7.01e-04 | 90 | 39 | 3 | int:TAGLN | |
| Interaction | MBD6 interactions | 7.24e-04 | 91 | 39 | 3 | int:MBD6 | |
| Interaction | RPS23 interactions | 7.26e-04 | 373 | 39 | 5 | int:RPS23 | |
| Interaction | BAP1 interactions | 7.38e-04 | 1314 | 39 | 9 | int:BAP1 | |
| Interaction | SLX4 interactions | 7.49e-04 | 572 | 39 | 6 | int:SLX4 | |
| Interaction | MYOT interactions | 7.49e-04 | 21 | 39 | 2 | int:MYOT | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 4.89e-03 | 404 | 39 | 3 | chr1q21 | |
| Cytoband | 21q22.3 | 5.34e-03 | 128 | 39 | 2 | 21q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 6.09e-03 | 137 | 39 | 2 | chr1p35 | |
| GeneFamily | Collagens | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 3.81e-15 | 46 | 29 | 8 | 490 |
| GeneFamily | Neuroblastoma breakpoint family | 6.43e-06 | 23 | 29 | 3 | 662 | |
| Coexpression | NABA_COLLAGENS | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 1.56e-15 | 43 | 39 | 8 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 1.90e-15 | 44 | 39 | 8 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 5.33e-09 | 270 | 39 | 8 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A6 COL5A1 COL6A1 COL11A2 COL16A1 COL25A1 COL19A1 COL28A1 | 6.16e-09 | 275 | 39 | 8 | M5884 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 9.67e-08 | 29 | 39 | 4 | MM17055 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 2.45e-06 | 18 | 39 | 3 | M47984 | |
| Coexpression | GU_PDEF_TARGETS_UP | 3.78e-06 | 71 | 39 | 4 | M3955 | |
| Coexpression | NABA_MATRISOME | COL4A6 COL5A1 COL6A1 COL11A2 C1QTNF7 COL16A1 COL25A1 COL19A1 COL28A1 | 1.33e-05 | 1008 | 39 | 9 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A6 COL5A1 COL6A1 COL11A2 C1QTNF7 COL16A1 COL25A1 COL19A1 COL28A1 | 1.53e-05 | 1026 | 39 | 9 | M5889 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 4.66e-05 | 268 | 39 | 5 | M45796 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 8.28e-05 | 493 | 39 | 6 | M19391 | |
| Coexpression | HOLLEMAN_DAUNORUBICIN_B_ALL_DN | 1.41e-04 | 12 | 39 | 2 | M2557 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 1.43e-04 | 68 | 39 | 3 | M1497 | |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 1.50e-04 | 181 | 39 | 4 | M8187 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 1.71e-04 | 563 | 39 | 6 | M15103 | |
| Coexpression | PEREZ_TP63_TARGETS | 1.77e-04 | 356 | 39 | 5 | M10761 | |
| Coexpression | KRAS.DF.V1_DN | 1.92e-04 | 193 | 39 | 4 | M2861 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 2.15e-04 | 199 | 39 | 4 | M3197 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP | 2.20e-04 | 200 | 39 | 4 | M3415 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 2.31e-04 | 80 | 39 | 3 | MM646 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON | 2.55e-04 | 16 | 39 | 2 | M5718 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.89e-04 | 17 | 39 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.89e-04 | 17 | 39 | 2 | MM1297 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 3.38e-04 | 91 | 39 | 3 | M40180 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.65e-06 | 243 | 37 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 6.59e-06 | 70 | 37 | 4 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 2.22e-05 | 95 | 37 | 4 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.57e-04 | 475 | 37 | 6 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 2.40e-04 | 984 | 37 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | 2.97e-04 | 761 | 37 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 3.66e-04 | 357 | 37 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.73e-04 | 197 | 37 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.73e-04 | 197 | 37 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K2 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.79e-07 | 160 | 39 | 5 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.42e-07 | 183 | 39 | 5 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.36e-07 | 189 | 39 | 5 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 6.53e-07 | 190 | 39 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 192 | 39 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 192 | 39 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-07 | 196 | 39 | 5 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.80e-07 | 197 | 39 | 5 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.00e-07 | 198 | 39 | 5 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.00e-07 | 198 | 39 | 5 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 8.20e-07 | 199 | 39 | 5 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-07 | 200 | 39 | 5 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.68e-06 | 149 | 39 | 4 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.64e-06 | 153 | 39 | 4 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.64e-06 | 153 | 39 | 4 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.64e-06 | 153 | 39 | 4 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 159 | 39 | 4 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 168 | 39 | 4 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 168 | 39 | 4 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 177 | 39 | 4 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 177 | 39 | 4 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.75e-05 | 178 | 39 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-05 | 178 | 39 | 4 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-05 | 178 | 39 | 4 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-05 | 181 | 39 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-05 | 181 | 39 | 4 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-05 | 181 | 39 | 4 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.87e-05 | 181 | 39 | 4 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.91e-05 | 182 | 39 | 4 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 183 | 39 | 4 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 183 | 39 | 4 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-05 | 184 | 39 | 4 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.99e-05 | 184 | 39 | 4 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.03e-05 | 185 | 39 | 4 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-05 | 185 | 39 | 4 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-05 | 185 | 39 | 4 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 186 | 39 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-05 | 186 | 39 | 4 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-05 | 188 | 39 | 4 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-05 | 188 | 39 | 4 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 2.17e-05 | 188 | 39 | 4 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-05 | 188 | 39 | 4 | 459e3fd4335a6f25f982d011b38702f4fcfed1cd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-05 | 188 | 39 | 4 | 9fd262bbf6cdebfd945e39428a6059726fb55b3a | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.21e-05 | 189 | 39 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 189 | 39 | 4 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 190 | 39 | 4 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 190 | 39 | 4 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 190 | 39 | 4 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 190 | 39 | 4 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 191 | 39 | 4 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 191 | 39 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 191 | 39 | 4 | d1205aab0937f2becfcd239610e9b78fb8a0c886 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-05 | 192 | 39 | 4 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-05 | 192 | 39 | 4 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-05 | 192 | 39 | 4 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.35e-05 | 192 | 39 | 4 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-05 | 192 | 39 | 4 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-05 | 192 | 39 | 4 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-05 | 192 | 39 | 4 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 192 | 39 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-05 | 193 | 39 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | facs-Lung-EPCAM-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | b9ac74357435f2f24aaede62b2a1d31b5d96a12c | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-05 | 193 | 39 | 4 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-05 | 193 | 39 | 4 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-05 | 193 | 39 | 4 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-05 | 194 | 39 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-05 | 194 | 39 | 4 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 194 | 39 | 4 | 04ecb609d233a4b12e275c604810937830363e17 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 194 | 39 | 4 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-05 | 194 | 39 | 4 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-05 | 194 | 39 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 194 | 39 | 4 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.45e-05 | 194 | 39 | 4 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 194 | 39 | 4 | 775600880bb77781de48085d8744c1030223de1f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-05 | 194 | 39 | 4 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 194 | 39 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.45e-05 | 194 | 39 | 4 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 194 | 39 | 4 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 194 | 39 | 4 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.50e-05 | 195 | 39 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-05 | 195 | 39 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 195 | 39 | 4 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 195 | 39 | 4 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 195 | 39 | 4 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-05 | 195 | 39 | 4 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 195 | 39 | 4 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.50e-05 | 195 | 39 | 4 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 195 | 39 | 4 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| Drug | AC1LAKND | 9.25e-12 | 62 | 38 | 7 | CID000470146 | |
| Drug | BAPN | 2.47e-11 | 71 | 38 | 7 | CID000001647 | |
| Drug | GK-101 | 2.68e-11 | 36 | 38 | 6 | CID000161853 | |
| Drug | halofuginone lactate | 9.03e-11 | 85 | 38 | 7 | CID000062891 | |
| Drug | Madecassol | 1.27e-10 | 46 | 38 | 6 | CID000108062 | |
| Drug | 4-hydroxyproline | 1.47e-10 | 91 | 38 | 7 | CID000000825 | |
| Drug | d-indobufen | 2.15e-10 | 50 | 38 | 6 | CID000044562 | |
| Drug | ridogrel | 2.75e-10 | 52 | 38 | 6 | CID005362391 | |
| Drug | NSC49633 | 3.10e-10 | 53 | 38 | 6 | CID000023340 | |
| Drug | ticlopidine | 3.55e-10 | 103 | 38 | 7 | CID000005472 | |
| Drug | hydroxylysine | 5.30e-10 | 109 | 38 | 7 | CID000001029 | |
| Drug | Tranilast sodium | 7.73e-10 | 115 | 38 | 7 | CID000005527 | |
| Drug | silibinin | COL4A6 COL5A1 COL6A1 PRKCD PARP1 COL11A2 COL16A1 COL25A1 COL19A1 | 7.89e-10 | 285 | 38 | 9 | CID000005213 |
| Drug | malotilate | 1.89e-09 | 71 | 38 | 6 | CID000004006 | |
| Drug | DMSe | 2.04e-09 | 132 | 38 | 7 | CID000020796 | |
| Drug | AC1NMZ1B | 2.65e-09 | 75 | 38 | 6 | CID005034185 | |
| Drug | pirfenidone | 2.78e-09 | 138 | 38 | 7 | CID000040632 | |
| Drug | DL-penicillamine | 2.93e-09 | 139 | 38 | 7 | CID000004727 | |
| Drug | PCR 4099 | 2.93e-09 | 139 | 38 | 7 | CID000002806 | |
| Drug | strontium ranelate | 3.11e-09 | 77 | 38 | 6 | CID006918182 | |
| Drug | candesartan cilexetil | 3.93e-09 | 145 | 38 | 7 | CID000002540 | |
| Drug | khellin | 1.24e-08 | 171 | 38 | 7 | CID000003828 | |
| Drug | AC1L1DD6 | 1.70e-08 | 179 | 38 | 7 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 2.47e-08 | 189 | 38 | 7 | CID000001413 | |
| Drug | AC1L1C2F | 2.70e-08 | 110 | 38 | 6 | CID000001711 | |
| Drug | PPACK | 3.17e-08 | 113 | 38 | 6 | CID003036757 | |
| Drug | AC1L9732 | 3.34e-08 | 114 | 38 | 6 | CID000439300 | |
| Drug | AC1L18QD | 5.33e-08 | 325 | 38 | 8 | CID000000213 | |
| Drug | Selara | 5.80e-08 | 125 | 38 | 6 | CID000150310 | |
| Drug | AC1L1KMJ | COL4A6 COL5A1 COL6A1 PRKCD COL11A2 COL16A1 COL25A1 COL19A1 MARCO | 6.73e-08 | 476 | 38 | 9 | CID000030956 |
| Drug | AC1Q6PCP | 9.47e-08 | 230 | 38 | 7 | CID000005267 | |
| Drug | L-3,4-dehydroproline | 1.36e-07 | 73 | 38 | 5 | CID000094284 | |
| Drug | losartan | 1.70e-07 | 378 | 38 | 8 | CID000003961 | |
| Drug | hyaluronan | 2.36e-07 | 263 | 38 | 7 | CID000024759 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.70e-07 | 162 | 38 | 6 | CID000072363 | |
| Drug | foscarnet | 6.90e-07 | 190 | 38 | 6 | CID000003414 | |
| Drug | colchine | 2.91e-06 | 383 | 38 | 7 | CID000002833 | |
| Drug | prostacyclin sodium salt | 3.39e-06 | 250 | 38 | 6 | CID000000159 | |
| Drug | chondroitin sulfate | 4.77e-06 | 413 | 38 | 7 | CID000024766 | |
| Drug | Coal Ash | 6.50e-06 | 159 | 38 | 5 | ctd:D060729 | |
| Drug | Y-27632 | 7.66e-06 | 444 | 38 | 7 | CID000005711 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.25e-05 | 314 | 38 | 6 | CID000447989 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.54e-05 | 190 | 38 | 5 | 1044_DN | |
| Drug | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | 2.26e-05 | 33 | 38 | 3 | ctd:C110772 | |
| Drug | NSC606985 | 2.70e-05 | 5 | 38 | 2 | ctd:C514334 | |
| Drug | aspirin | 3.53e-05 | 563 | 38 | 7 | CID000002244 | |
| Drug | LS-63783 | 4.46e-05 | 804 | 38 | 8 | CID000000231 | |
| Drug | PCB 52 | 5.80e-05 | 45 | 38 | 3 | CID000037248 | |
| Drug | Methamphetamine | PRKCD FLNA PARP1 FLNC C1QTNF7 COL25A1 MYO18B PCBP4 DNAJA4 COL28A1 | 7.28e-05 | 1401 | 38 | 10 | ctd:D008694 |
| Drug | PCB-151 | 7.55e-05 | 8 | 38 | 2 | CID000040471 | |
| Drug | AC1L1E3X | 7.55e-05 | 8 | 38 | 2 | CID000053037 | |
| Drug | ADP-Rib | 8.09e-05 | 269 | 38 | 5 | CID000000192 | |
| Drug | CAS 68-19-9 | 9.84e-05 | 145 | 38 | 4 | CID000002891 | |
| Drug | PCB 66 | 1.48e-04 | 11 | 38 | 2 | CID000036185 | |
| Drug | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | 1.77e-04 | 12 | 38 | 2 | ctd:C403754 | |
| Drug | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone | 2.09e-04 | 13 | 38 | 2 | ctd:C427308 | |
| Drug | PCB 81 | 2.09e-04 | 13 | 38 | 2 | CID000051043 | |
| Drug | Cortisporin | 2.12e-04 | 177 | 38 | 4 | CID000004454 | |
| Drug | acetyl-aspartyl-glutamyl-valyl-aspartal | 2.44e-04 | 14 | 38 | 2 | ctd:C099158 | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; PC3; HT_HG-U133A | 2.78e-04 | 190 | 38 | 4 | 4637_UP | |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.95e-04 | 193 | 38 | 4 | 4788_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HG-U133A | 3.01e-04 | 194 | 38 | 4 | 428_DN | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 3674_DN | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 4082_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 5000_UP | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3263_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HG-U133A | 3.13e-04 | 196 | 38 | 4 | 1906_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2243_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3743_DN | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 6152_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4186_UP | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3388_UP | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4249_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 5829_UP | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 4251_UP | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3831_UP | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; PC3; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 5968_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 3932_UP | |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 5264_UP | |
| Drug | pyrachlostrobin | 3.41e-04 | 811 | 38 | 7 | ctd:C513428 | |
| Drug | wartmannin | 3.41e-04 | 811 | 38 | 7 | CID000005691 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 3.70e-04 | 373 | 38 | 5 | ctd:C540355 | |
| Drug | acetate | 4.36e-04 | 599 | 38 | 6 | CID000000175 | |
| Drug | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane | 4.56e-04 | 19 | 38 | 2 | ctd:C103712 | |
| Drug | AC1L9HPX | 4.86e-04 | 92 | 38 | 3 | CID000445279 | |
| Drug | 351A | 5.06e-04 | 20 | 38 | 2 | CID000122144 | |
| Drug | AD 198 | 5.06e-04 | 20 | 38 | 2 | CID000127201 | |
| Disease | myopathy (implicated_via_orthology) | 3.11e-07 | 48 | 35 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | collagen alpha-1(VI) chain measurement | 1.37e-06 | 2 | 35 | 2 | EFO_0801487 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 4.10e-06 | 3 | 35 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 4.10e-06 | 3 | 35 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | response to ondansetron, QT interval | 7.47e-05 | 11 | 35 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | Colorectal Carcinoma | 1.60e-04 | 702 | 35 | 6 | C0009402 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 2.31e-04 | 19 | 35 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Early Pregnancy Loss | 2.94e-04 | 109 | 35 | 3 | C3830362 | |
| Disease | Miscarriage | 2.94e-04 | 109 | 35 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 2.94e-04 | 109 | 35 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 2.94e-04 | 109 | 35 | 3 | C0000822 | |
| Disease | spine bone mineral density | 3.81e-04 | 119 | 35 | 3 | EFO_0007701 | |
| Disease | intestinal permeability measurement | 4.36e-04 | 26 | 35 | 2 | EFO_0011031 | |
| Disease | Autosomal Dominant Parkinsonism | 5.07e-04 | 28 | 35 | 2 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 5.07e-04 | 28 | 35 | 2 | C0752097 | |
| Disease | Parkinsonism, Experimental | 5.07e-04 | 28 | 35 | 2 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 5.07e-04 | 28 | 35 | 2 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 5.07e-04 | 28 | 35 | 2 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 5.07e-04 | 28 | 35 | 2 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 5.07e-04 | 28 | 35 | 2 | C1868675 | |
| Disease | Parkinsonism, Juvenile | 5.82e-04 | 30 | 35 | 2 | C0752105 | |
| Disease | Parkinsonian Disorders | 5.82e-04 | 30 | 35 | 2 | C0242422 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEKGEGGQKEIEFGT | 106 | P11171 | |
| LGTTGEKGEKGEKGI | 281 | Q14031 | |
| DGVEGENGGETKKSK | 581 | P49711 | |
| TKGEKGDIGIGIAGE | 1516 | Q07092 | |
| GKKVIELGAGTGIVG | 76 | Q96AZ1 | |
| EKCEGVGGKKGSVEK | 136 | Q8WW22 | |
| EKIKLEGGIKGIGKT | 1206 | Q12830 | |
| GVKSEGKRKGDEVDG | 201 | P09874 | |
| GKEVGSIIGKKGETV | 26 | P57723 | |
| HGKEVGSIIGKKGES | 21 | Q15365 | |
| GKGSFGKVLLGELKG | 356 | Q05655 | |
| GKTGLIIGKGGETIK | 386 | Q96AE4 | |
| SKEGGKVTVKTEGGA | 56 | P13535 | |
| ETLINGKGKERGGKG | 221 | A6NKB5 | |
| KGDLGEKGEKGFRGV | 606 | Q9BXS0 | |
| TKGAGSGELKVTVKG | 501 | Q14315 | |
| DGIRGLKGHKGEKGE | 726 | P13942 | |
| GKGGSKIKEIRESTG | 146 | P57721 | |
| HGKEVGSIIGKKGES | 21 | Q15366 | |
| GSKTGGKEKETTGES | 386 | Q9BYI3 | |
| RGDVGKKGDKGEIGE | 741 | Q2UY09 | |
| EKGKRGIDGVDGVKG | 321 | P12109 | |
| KGETGEKGEQGEKGD | 336 | Q14993 | |
| GSGELKVTVKGPKGE | 511 | P21333 | |
| LGSSGGEKEEGKKVR | 146 | Q96RY5 | |
| GADGIRGLKGTKGEK | 796 | P20908 | |
| LIGPKGETGTKGEKG | 236 | Q9UEW3 | |
| VKGSSGEQGVKGEKG | 401 | Q9UEW3 | |
| GEKGEKGTAGLRGKT | 71 | Q9BXJ2 | |
| SGDVKEKKGKGSLGS | 1396 | Q13428 | |
| GFSLDVGEIEKKGKG | 1551 | Q6P3W6 | |
| GFSLDVGEIEKKGKG | 2771 | Q6P3W6 | |
| GFSLDVGEIEKKGKG | 1036 | A0A087WUL8 | |
| GFSLDVGEIEKKGKG | 2256 | A0A087WUL8 | |
| GFSLDVGEIEKKGKG | 3476 | A0A087WUL8 | |
| GFSLDVGEIEKKGKG | 936 | P0DPF2 | |
| GFSLDVGEIEKKGKG | 2156 | P0DPF2 | |
| GFSLDVGEIEKKGKG | 3376 | P0DPF2 | |
| GFSLDVGEIEKKGKG | 4521 | P0DPF2 | |
| KSGGKGGEDESVILK | 306 | Q9UNA1 | |
| GAIIAGGKGGAKEKI | 301 | P53597 | |
| SKGEKIKVLSIGEGG | 576 | Q9Y566 | |
| KKVASTLTEEGGGGG | 166 | Q8TF68 | |
| KEGETEGEVGTEKKG | 1296 | Q9C0A1 | |
| SVGEFVGEGEGKSKK | 221 | O95793 | |
| LKKGEEGQSIVGKGL | 231 | Q8IUG5 | |
| LGKTLGEGEFGKVVK | 726 | P07949 |